Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated October 30, 2023, titled "Sun Pharma and Zydus sign licensing agreement for co-marketing of Desidustat, a critical treatment for Chronic Kidney Disease patients in India".